Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pirfenidone in Progressive Fibrotic Sarcoidosis
NCT03260556Phase 4Unknown
- Sponsor
- University of Cincinnati
- Start
- Sep 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pirfenidone in pulmonary sarcoidosis, sponsored by University of Cincinnati. Status: unknown.
02
Drugs
pirfenidone
03
Conditions
pulmonary sarcoidosis
Beyond the preview
Go deeper on NCT03260556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03260556.